Regulation of activation-induced cell death of mature T-lymphocyte populations

Cell and Tissue Research

Volumn 301, Issue 1, 2000, Pages 85-99

  Janssen, Ottmar ^a   Sanzenbacher, Ralf ^b   Kabelitz, Dieter ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Activation induced cell death; Apoptosis; Immune regulation; Programmed cell death; T lymphocytes

Indexed keywords

CYTOKINE; FAS ANTIGEN; GROWTH FACTOR; INTERLEUKIN 2; LIGAND; NUCLEASE; PROTEINASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ANTIGEN SPECIFICITY; APOPTOSIS; AUTOIMMUNE DISEASE; CELL DEATH; CELL STIMULATION; CELLULAR IMMUNITY; GROWTH REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOTHERAPY; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION;

EID: 0033927918     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004419900155     Document Type: Review

References (250)

1. Abbas AK (1996) Die and let live: eliminating dangerous lymphocytes. Cell 84:655-657
2. + T cell clones with different T-helper phenotypes: role of CD95/CD95L interactions. Blood 89:558-569
3. Acha-Orbea H, Shakhov AN, Scarpellino L, Kolb E, Müller V, Vessaz-Shaw A, Fuchs R, Bölchlinger K, Rollini P, Billotte J, Sarafidou M, MacDonald HR (1991) Clonal deletion of Vβ14-bearing T cells in mice transgenic for mammary tumour virus. Nature 350:207-211
4. Adkins B, Chun K, Hamilton K, Nassiri M (1996) Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J Immunol 157:1343-1349
5. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH (1995) Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77
6. Algeciras A, Dockrell DH, Lynch DH, Paya CV (1998) CD4 regulates susceptibility to Fas ligand-and tumor necrosis factor-mediated apoptosis. J Exp Med 187:711-720
7. L in the action of interleukin-7 (IL-7): a survival factor in activated human T cells. Cytokine 10:3810-3815
8. Anderson P, Blue ML, Morimoto C, Schlossman SF (1987) Crosslinking of T3 (CD3) with T4 (CD4) enhances the proliferation of resting T lymphocytes. J Immunol 139:678-682
9. Anel A, Buferne M, Boyer C, Schmitt-Verhulst AM, Golstein P (1994) T cell receptor-induced CD95 ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur J Immunol 24:2469-2476
10. Arnold B, Schönrich G, Hämmerling GJ (1993) Multiple levels of peripheral tolerance. Immunol Today 14:12-14
11. Ayroldi E, Zollo O, Cannarile L, D'Adamio F, Grohmann U, Delfino DV, Riccardi C (1998) Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/Fas ligand expression and cell death. Blood 92:4212-4219
12. Baier M, Werner A, Bannert N, Metzner K, Kurth R (1995) HIV suppression by interleukin-16. Nature 378:563
13. Bajorath J, Aruffo A (1997) Prediction of the three-dimensional structure of the human Fas receptor by comparative molecular modeling. J Comput Aided Mol Des 11:3-8
14. Baldari CT, Milia E, Di Somma MM, Baldoni F, Valitutti S, Telford JL (1995) Distinct signaling properties identify functionally different CD4 epitopes. Eur J Immunol 25:1843-1850
15. Banda NK, Bernier J, Kurahara DK, Kurrle R, Haigwood N, Sekaly RP, Finkel TH (1992) Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J Exp Med 176:1099-1106
16. Bank I, Chess L (1985) Perturbation of the T4 molecule transmits a negative signal to T cells. J Exp Med 162:1294-1303
17. Banner DW, D'Arcy A, Janes W, Gentz R, Schoenfeld HJ, Broger C, Loetscher H, Lesslauer W (1993) Crystal structure of the soluble human 55 kd TNF receptor-human TNF-beta complex: implications for TNF receptor activation. Cell 73:431-445
18. Bensussan A, Leca G, Corva N, Boumsell L (1990) Selective induction of autocytotoxic activity through the CD3 molecule. Eur J Immunol 20:2615-2619
19. Bissonnette RP, McGahon A, Mahboubi A, Green DR (1994) Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas. J Exp Med 180:2413-2418
20. Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schroter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J (1997) TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor 1 and Fas(Apo-1/CD95). Immunity 6:79-88
21. Boehme SA, Lenardo MJ (1993) Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur J Immunol 23:1552-1560
22. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell 85:803-815
23. Bossy-Wetzel E, Newmeyer DD, Green D (1998) Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and dependently of mitochondrial transmembrane depolarization. EMBO J 17:37-49
24. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM (1997) Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 272:26159-26165
25. Breitmeyer JB, Oppenheim SO, Daley JF, Levine HB, Schlossman SF (1987) Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex. J Immunol 138:726-731
26. Brojatsch J, Naughton J, Rolls MM, Zingler K, Young YA (1996) CAR1, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcoma viruses and mediates apoptosis. Cell 87:845-855
27. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-444
28. Bustelo XR, Ledbetter JA, Barbacid M (1992) Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates. Nature 356:68-71
29. Campos L, Alfrey EJ, Posselt AM, Odorico JS, Barker CF, Naji A (1993) Prolonged survival of rat orthotopic liver allografts after intrathymic inoculation of donor-strain cells. Transplantation 55:866-870
30. Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, Rosen A (1996) Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med 182:1957-1964
31. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G (1996) Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol 157:512-521
32. Castro JE, Listman JA, Jacobson BA, Wang Y, Lopez PA, Ju S, Finn PW, Perkins DL (1996) Fas modulation of apoptosis during negative selection of thymocytes. Immunity 5:617-627
33. Center DM, Kornfeld H, Cruikshank WW (1996) Interleukin 16 and its function as a CD4 ligand. Immunol Today 17:476-481
34. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512
35. Chinnaiyan AM, O'Rourke K, Yu GL, Lyons RH, Garg M, Duan DR, Xing L, Gentz R, Ni J, Dixit VM (1996a) Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274:990-992
36. Chinnaiyan AM, Tepper CG, Seldin MF, O'Rourke K, Kischkel FC, Hellbardt S, Krammer PH, Peter ME, Dixit VM (1996b) FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J Biol Chem 271:4961-4965
37. Choy EHS, Adjave J, Forrest L, Kingsley GH, Panayi GS (1993) Chimaeric anti-CD4 monoclonal antibody cross-linked by monocyte Fcγ receptor mediates apoptosis of human CD4 lymphocytes. Eur J Immunol 23:2676-2681
38. Cifone MG, De Maria R, Roncaioli P, Rippo MR, Azuma M, Lanier LL, Santoni A, Testi R (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 180:1547-1552
39. Clements, JL, Ross-Barta SE, Tygrett LT, Waldschmidt TJ, Koretzky GA (1998a) SLP-76 expression is restricted to hemopoietic cells of monocyte, granulocyte, and T lymphocyte lineage and is regulated during T cell maturation and activation. J Immunol 161:3880-3889
40. Clements JL, Yang B, Ross-Barta SE, Eliason SL, Hrstka RF, Williamson RA, Koretzky GA (1998b) Requirement for the leukocyte-specific adapter protein SLP-76 for normal T cell development. Science 281:416-419
41. Cohen GM, Sun XM, Snowden RT, Dinsdale D, Skiletter DN (1992) Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 286:331-334
42. Collette Y, Benziane A, Razanajaona D, Olive D (1998) Distinct regulation of T-cell death by CD28 depending on both its aggregation and T-cell receptor triggering: a role for Fas-FasL. Blood 92:1350-1363
43. Collins TL, Deckert M, Altman A (1997) Views on Vav. Immunol Today 18:221-225
44. Combadière B, Freedman M, Chen L, Shores EW, Love P, Lenardo MJ (1996) Qualitative and quantitative contributions of the T cell receptor ζ chain to mature T cell apoptosis. J Exp Med 183:2109-2117
45. lck. J Exp Med 183:39-48
46. Cruikshank WW, Lim K, Theodore AC, Cook J, Fine G, Weller PF, Center DM (1996) IL-16 inhibition of CDS-dependent lymphocyte activation and proliferation. J Immunol 157:5240-5248
47. D'Adamio L, Awad KM, Reinherz EL (1993) Thymic and peripheral apoptosis of antigen-specific T cells might cooperate in establishing self tolerance. Eur J Immunol 23:747-753
48. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C (1997) A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803-812
49. da Silva AJ, Li Z, De Vera C, Canto E, Findell P, Rudd CE (1997) Cloning of a novel T-cell protein FYB that binds FYN and SH2-domain-containing leukocyte protein 76 and modulates interleukin 2 production. Proc Natl Acad Sci USA 94: 7493-7498
50. Degli-Esposti M (1999) To die or not to die - the quest of the TRAIL receptors. J Leukocyte Biol 65:535-542
51. Degli-Esposti MA, Smolak PJ, Walczak H, Waugh J, Huang CP, DuBose RF, Goodwin RG, Smith CA (1997a) Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186:1165-1170
52. Degli-Esposti MA, Dongali WC, Smolak P, Walczak H, Waugh JY, Smith CA, Goodwin RG (1997b) The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7:813-820
53. + T cells. Proc Natl Acad Sci U S A 93:11014-11018
54. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH (1995) Autocrine T-cell suicide mediated by APO-1/ (Fas/CD95). Nature 373:438-441
55. Dianzani U, Shaw A, Fernandez-Cabezuda M, Janeway CA Jr (1992) Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen. Int Immunol 4:995-1001
56. lck plays a key role in transducing apoptotic signals in T cells. FEBS Lett 363:101-104
57. Dong Z, Sikumar P, Weinberg JM, Venkatachalam MA (1997) Internucleosomal DNA cleavage triggered by plasma membrane damage during necrotic cell death: involvement of serine but not cysteine proteases. Am J Pathol 151:1205-1213
58. + thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci U S A 90:10340-10344
59. Duvall E, Wyllie AH (1986) Death and the cell. Immunol Today 7:115-119
60. Eck MJ, Sprang SR (1989) The structure of tumor necrosis factor-alpha at 2.6-A resolution: implications for receptor binding. J Biol Chem 264:17595-17605
61. Eck MJ, Ultsch M, Rinderknecht E, de Vos AM, Sprang SR (1992) The structure of human lymphotoxin (tumor-necrosis-factor-beta) at 1.9-Å resolution. J Biol Chem 267:2119-2122
62. Eischen CM, Dick CJ, Leibson PJ (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J Immunol 153:1947-1954
63. Fadeel B, Lindberg J, Achour A, Chiodi F (1998) A three-dimensional model of the Fas/APO-1 molecule: cross-reactivity of anti-Fas antibodies explained by structural mimicry of antigenic sites. Int Immunol 10:131-140
64. Falb D, Briner TJ, Sunshine GH, Bourque CR, Luqman M, Gefter ML, Kamradt T (1996) Peripheral tolerance in T cell receptor-transgenic mice: evidence for T cell anergy. Eur J Immunol 26:130-135
65. Farber DL, Luqman M, Acuto O, Bottomly K (1995) Control of memory CD4T cell activation: MHC class II molecules on APCs and CD4 ligation inhibit memory but not naive CD4T cells. Immunity 2:249-259
66. Fernandez-Alnemri T, Litwack MG, Alnemri ES (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J Biol Chem 269:30761-30764
67. Fisher GH, Lenardo MJ, Zúñiga-Pflücker JC (1996) Synergy between T cell receptor and Fas (CD95/APO-1) signaling in mouse thymocyte death. Cell Immunol 169:99-106
68. Gajewski TF, Pinnas M, Wong T, Fitch FW (1991) Murine Th1 and Th2 clones proliferate optimally in response to distinct antigen-presenting cell populations. J Immunol 146:1750-1758
69. lck by gp120, a model for TCR desensitization. J Immunol 158:2017-2024
70. Golstein P (1997) Cell death: TRAIL and its receptors. Curr Biol 7:750-753
71. Gonzalez-Garcia A, Borlado LR, Leonardo E, Mérida I, Martinez AC, Carrera AC (1997) Lck is necessary and sufficient for Fas-Ligand expression and apoptotic cell death in mature cycling T cells. J Immunol 158:4104-4112
72. Gonzalo JA, Baixeras E, Gonzalez-Garcia A, George-Chandy A, Van Rooijen N, Martinez C, Kroemer G (1994) Differential in vivo effects of a superantigen and an antibody targeted to the same T cell receptor. Activation-induced cell death vs passive macrophage-dependent deletion. J Immunol 152:1597-1608
73. Gougeon ML, Montagnier L (1993) Apoptosis in AIDS. Science 260:1269-1272
74. Griffith TS, Lynch DH (1998) TRAIL: a molecule with multiple receptors and control mechanisms. Curr Opin Immunol 10: 559-563
75. Groux H, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC (1992) Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 175:331-340
76. Gulbins E, Bissonette R, Mahboubi A, Martin S, Nishioka W, Brunner T, Baier G, Baier-Bitterlich G, Byrd C, Lang F, Kolesnick R, Altman A, Green D (1995) Fas-induced apoptosis is mediated via a ceramide-initiated Ras signaling pathway. Immunity 2:341-351
77. 2-synthesis. Immunology 89:205-212
78. He YW, Deftos ML, Ojala EW, Bevan MJ (1998) RORgamma t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells. Immunity 9:797-806
79. --and 'activating' memory T cells. Clin Exp Immunol 95:195-200
80. Hu S, Vincenz C, Ni J, Gentz R, Dixit VM (1997) I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1-and CD-95-induced apoptosis. J Biol Chem 272:17255-17257
81. Idziorek T, Khalife J, Billaut-Mulot O, Hermann E, Aumencier M, Mouton Y, Capron A, Bahr GM (1998) Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD). Clin Exp Immunol 112:84-91
82. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
83. Itoh N, Nagata S (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem 268:10932-10937
84. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243
85. Jabado N, Pallier A, Le Deist F, Bernard F, Fischer A, Hivroz C (1997) CD4 ligands inhibit the formation of multifunctional transduction complexes involved in T cell activation. J Immunol 158:94-103
86. Jackman JK, Motto DG, Sun Q, Tanemoto M, Turck CW, Peltz GA, Koretzky GA, Findell PR (1995) Molecular cloning of SLP-76, a 76-kDa tyrosine phosphoprotein associated with Grb2 in T cells. J Biol Chem 270:7029-7032
87. + T cells. J Immunol 146:35-39
88. Janssen O, Wesselborg S, Kabelitz D (1992) Immunosuppression by OKT3-induction of programmed cell death (apoptosis) as a possible mechanism of action. Transplantation 53:233-234
89. Janssen O, Lengl-Janßen B, Oberg H-H, Robertson MJ, Kabelitz D (1996) Induction of cell death via Fas (CD95, APO-1) may be associated with but is not dependent on Fas-induced tyrosine phosphorylation. Immunol Lett 49:63-69
90. Janssen O, Stocker A, Sanzenbacher R, Oberg H-H, Siddiqi MA, Kabelitz D (2000) Differential regulation of activation-induced cell death (AICD) in individual human T cell clones. Int Arch Allergy Immunol: in press
91. Jenkinson EJ, Kingston R, Smith CA, Williams GT, Owen JJT (1989) Antigen-induced apoptosis in developing T cells: a mechanism for negative selection of the T cell receptor repertoire. Eur J Immunol 19:2175-2177
92. Ju ST, Panka DJ, Cui H, Ettinger R, el-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-448
93. June CH, Fletcher MC, Ledbetter JA, Schieven GL, Siegel JN, Phillips AF, Samelson LE (1990) Inhibition of tyrosine phosphorylation prevents T-cell receptor-mediated signal transduction. Proc Natl Acad Sci U S A 87:7722-7726
94. Kabelitz D, Janssen O (1997) Antigen-induced death of T-lymphocytes. Front Biosci 2:61-77
95. Kabelitz D, Pohl T, Pechhold K (1993) Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338-339
96. Kasibhatla S, Genestier L, Green DR (1999) Regulation of Fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J Biol Chem 274:987-992
97. Katsikis PD, García-Ojeda ME, Wunderlich ES, Smith CA, Yagita H, Okumura K, Kayagaki N, Alderson M, Herzenberg LA (1996) Activation-induced peripheral blood T cell apoptosis is Fas independent in HIV-infected individuals. Int Immunol 8:1311-1317
98. Katzav S, Martin-Zanca D, Barbacid M (1989) Vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. EMBO J 8:2283-2290
99. + T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 349:245-248
100. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H (1995) Metalloproteinase-mediated release of human Fas ligand. J Exp Med 182:1777-1783
101. Kerr JFR, Harmon BV (1991) Definition and incidence of apoptosis: an historical perspective. In: Tomei LD, Cope FO (eds) Apoptosis: the molecular basis of cell death. Cold Spring Harbor Laboratory Press, New York, pp 5-29
102. Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257
103. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14:5579-5588
104. Kisielow P, von Boehmer H (1995) Development and selection of T cells: facts and puzzles. Adv Immunol 58:87-209
105. Klas C, Debatin KM, Jonker R, Krammer PH (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625-630
106. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
107. Koretzky GA (1997) The role of Grb2-associated proteins in T cell activation. Immunol Today 8:401-406
108. Krammer PH (1999) CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv Immunol 71:163-210
109. Kroemer G (1995) The pharmacology of T cell apoptosis. Adv Immunol 58:211-296
110. Kroemer G, Martinez-AC (eds) (1995) Apoptosis in immunology. Current topics in microbiology and immunology, vol 200, Springer, Berlin Heidelberg New York
111. Latinis KM, Koretzky GA (1996) Fas ligation induces apoptosis and Jun kinase activation independently of CD45 and Lck in human T cells. Blood 87:871-875
112. Latinis KM, Norian LA, Eliason SL, Koretzky GA (1997) Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 272:31427-31434
113. Ledbetter JA, June CH, Rabinovitch PS, Grossmann A, Tsu TT, Imboden JB (1988) Signal transduction through CD4 receptors: stimulatory vs inhibitory activity is regulated by CD4 proximity to the CD3/TCR receptor. Eur J Immunol 18:525-532
114. Lenardo MJ (1991) Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858-861
115. Lenardo M, Chan FK-M, Hornung F, McFarland H, Siegel R, Wang J, Zheng L (1999) Mature T lymphocyte apoptosis - immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 17:221-253
116. Liegler TJ, Stites DP (1994) HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4T lymphocytes. J Acquir Immun Defic Syndr 7:340-348
117. Liu Z-G, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA (1994) Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-284
118. Li-Weber M, Laur O, Hekele A, Coy J, Walczak H, Krammer PH (1998) A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. Eur J Immunol 28:2373-2383
119. Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W (1990) Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 61:351-359
120. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droge W, Krammer PH, Fiers W, Schulze-Osthoff K (1995) Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375:81-83
121. Los M, Wesselborg S, Schulze-Osthoff K (1999) The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. Immunity 10:629-639
122. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G (1996) Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184:1155-1160
123. Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, Weiss A, Schlessinger J (1992) Tyrosine phosphorylation of vav protooncogene product containing SH2 domain and transcription factor motifs. Nature 356:71-74
124. Mariani SM, Matiba B, Bäumler C, Krammer PH (1995) Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25:2302-2307
125. Mariani SM, Matiba B, Krammer PH (1996) CD95 (APO-1/Fas) and its ligand in the mouse immune system. Behring Inst Mitt 97:12-23
126. Markmann JF, Odorico JS, Bassiri H, Desai N, Kim JI, Barker CF (1993) Deletion of donor-reactive T lymphocytes in adult mice after intrathymic inoculation with lymphoid cells. Transplantation 55:871-877
127. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR (1995) Early redistribution of plasma membrane phosphotidylserine is a general feature of apoptosis regardless of initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 182:1545-1556
128. McCarthy SA, Cacchione RN, Mainwaring MS, Cairns JS (1992) The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. Transplantation 54:543-547
129. McConkey DJ, Hartzell P, Amador-Pérez JF, Orrenius S, Jondal M (1989) Calcium-dependent killing of immature thymocytes by stimulation via the CD3/T cell receptor complex. J Immunol 143:1801-1806
130. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 16:2794-2804
131. Mercep M, Bluestone JA, Noguchi PD, Ashwell JD (1988) Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J Immunol 140:324-335
132. Meuer SC, Hodgdon JC, Hussey RE, Protentis JP, Schlossman SF, Reinherz EL (1983) Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones. J Exp Med 158:988-993
133. Meuer SC, Hussey RE, Cantrell DA, Hodgdon JC, Schlossman SF, Smith KA, Reinherz EL (1984) Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A 81:1509-1513
134. Migita K, Eguchi K, Yojiro K, Mizokami A, Tsukada T, Nagataki S (1994) Prevention of anti-CD3 monoclonal antibody-induced thymic apoptosis by protein tyrosine kinase inhibitors. J Immunol 153:3457-3465
135. Migita K, Eguchi K, Kawabe Y, Tsukada T, Mizokami A, Nagataki S (1995) FK506 augments activation-induced programmed cell death of T lymphocytes in vivo. J Clin Invest 96:727-732
136. Mittelstadt PR, Ashwell JD (1998) Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol Cell Biol 18:3744-3751
137. Mittler RS, Hoffmann MK (1989) Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380-1382
138. Mollereau B, Deckert M, Déas O, Rieux-Laucat F, Hirsch F, Bernard A, Fischer A, Lynch DH, Charpentier B, Le Deist F, Senik A (1996) CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol 156:3184-3190
139. Mosmann TR, Coffman RL (1989) TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173
140. Motto DG, Ross SE, Wu J, Hendricks-Taylor LR, Koretzky GA (1996) Implication of the Grb2-associated phosphoprotein SLP-76 in T cell receptor-mediated interleukin 2 production. J Exp Med 183:1937-1943
141. Muñoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med 172:95-103
142. Musci MA, Hendricks-Taylor LR, Motto DG, Paskind M, Kamens J, Turck CW, Koretzky GA (1997) Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases. J Biol Chem 272:11674-11677
143. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85:817-827
144. Nagata S, Golstein P (1995) The Fas death factor. Science 267: 1449-1456
145. Nakafusa Y, Goss JA, Mohanakumar T, Flye MW (1993) Induction of donor-specific tolerance to cardiac but not skin or renal allografts by intrathymic injection of splenocyte alloantigen. Transplantation 55:877-882
146. Nau GJ, Moldwin RL, Lancki DW, Kim DK, Fitch FW (1987) Inhibition of IL 2-driven proliferation of murine T lymphocyte clones by supraoptimal levels of immobilized anti-T cell receptor monoclonal antibody. J Immunol 139:114-122
147. Nau GJ, Kim DK, Fitch FW (1988) Agents that mimic antigen receptor signaling inhibit proliferation of cloned murine T lymphocytes induced by IL-2. J Immunol 141:3557-3563
148. Newell MK, Haughn LJ, Maroun CR, Julius MH (1990) Death of mature T cells by separate ligation of CD4 and the T cell receptor for antigen. Nature 347:286-289
149. Nicholson D, Thornberry N (1997) Caspases: killer proteases. Trends Biochem Sci 22:299-306
150. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, Miller DK (1995) Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37-43
151. Obeid LM, Linardic CM, Karolak LA, Hannun YA (1993) Programmed cell death induced by ceramide. Science 259:1769-1771
152. Oberg H-H, Lengl-Janßen B, Robertson MJ, Kabelitz D, Janssen O (1997a) Differential role of tyrosine phosphorylation in the induction of apoptosis in T cell clones via CD95 or the TCR/CD3-complex. Cell Death Diff 4:403-412
153. Oberg H-H, Sanzenbacher R, Lengl-Janssen B, Dobmeyer T, Flindt S, Janssen O, Kabelitz D (1997b) Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression. J Immunol 159:5742-5749
154. Oberg H-H, Lengl-Janßen B, Kabelitz D, Janssen O (1997c) Activation-induced T cell death: resistance or susceptibility correlate with cell surface Fas ligand expression and T helper phenotype. Cell Immunol 181:93-100
155. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715
156. O'Hehir RE, Lamb JR (1990) Induction of specific clonal anergy in human T lymphocytes by Staphyloccus aureus enterotoxins. Proc Natl Acad Sci U S A 87:8884-8888
157. Okada C, Kizaki H, Tadakuma T (1990) T cell receptor-mediated DNA fragmentation and cell death in T cell hybridomas. J Immunol 144:2096-2101
158. Oravecz T, Norcross MA (1993) Costimulatory properties of the human CD4 molecule: enhancement of CD3-induced T cell activation by human immunodeficiency virus type 1 through viral envelope glycoprotein gp120. AIDS Res and Hum Retrovir 9:945-955
159. Oyaizu N, McCloskey TW, Coronesi M, Chirmule N, Kalyanaraman VS, Pahwa S (1993) Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392-3400
160. lck in T-cell receptor/CD3-mediated apoptosis and Fas-ligand induction in Jurkat cells. Biochem Biophys Res Commun 213:994-1001
161. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM (1997a) The receptor for the cytotoxic ligand TRAIL. Science 276:111-113
162. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997b) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818
163. Pan G, Bauer JH, Haridas V, Wang S, Liu D, Yu G, Vincenz C, Aggarwal BB, Ni J, Dixit VM (1998) Identification and functional characterization of DR6, a novel death domain-containing TNF receptor. FEBS Lett 431:351-356
164. Pearson TT, Darby CR, Bushell AR, West LJ, Morris PJ, Wood KJ (1993) The assessment of transplantation tolerance induced by anti-CD4 monoclonal antibody in the murine model. Transplantation 55:361-367
165. Peitsch MC, Tschopp J (1995) Comparative molecular modeling of the Fas-ligand and other members of the TNF family. Mol Immunol 32:761-772
166. Peter ME, Krammer PH (1998) Mechanisms of CD95(APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 10:545-551
167. Peter ME, Dhein J, Ehret A, Hellbardt S, Walczak H, Moldenhauer G, Krammer PH (1995) APO-1(CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int Immunol 7:1873-1877
168. Peter ME, Kischkel FC, Scheuerpflug CG, Medema JP, Debatin KM, Krammer PH (1997) Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex. Eur J Immunol 27:1207-1212
169. Pivniouk V, Tsitsikov E, Swinton P, Rathbun G, Alt FW, Geha RS (1998) Impaired viability and profound block in thymocyte development in mice lacking the adaptor protein SLP-76. Cell 94:229-238
170. Portolés P, de Ojeda G, Criado G, Fernandéz-Centeno E, Rojo JM (1999) Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4+ T lymphocytes. Cell Immunol 195:96-109
171. Raab M, Da Silva AJ, Findell PR, Rudd CE (1997) Regulation of Vav-SLP-76 binding by ZAP-70 and its relevance to TCRζ/CD3 induction of interleukin-2. Immunity 6:155-164
172. Radvanyi LG, Mills GB, Miller RG (1993) Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death. J Immunol 150: 5704-5715
173. Radvanyi LG, Shi Y, Vaziri H, Sharma A, Dhala R, Mills GB, Miller RG (1996) CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J Immunol 156: 1788-1798
174. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH (1994) Differential ability of Th1 and Th2T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6:1545-1553
175. Rathmell JC, Thompson CB (1999) The central effectors of cell death in the immune system. Annu Rev Immunol 17:781-828
176. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195-200
177. Rudd CE, Janssen O, Cai YC, da Silva AJ, Raab M, Prasad KVS (1994) Two-step TCRζ/CD3-CD4 and CD28 signaling in T cells: SH2/SH3 domains, protein-tyrosine kinases and lipid kinases. Immunol Today 15:225-234
178. Russell JH (1995) Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7: 382-388
179. Russell JH, White CL, Loh DY, Meleedy-Rey P (1991) Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci U S A 88:2151-2155
180. Russell JH, Rush BJ, Abrams SI, Wang R (1992) Sensitivity of T cells to anti-CD3-stimulated suicide is independent of functional phenotype. Eur J Immunol 22:1655-1658
181. Sallusto F, Lanzavecchia A, Mackay CR (1998a) Chemokines and chemokine receptors in T-cell priming and Th1/Th2-mediated responses. Immunol Today 19:568-574
182. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A (1998b) Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med 187:875-883
183. Salmon M, Pilling D, Borthwick NJ, Viner N, Janossy G, Bacon PA, Akbar AN (1994) The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 24:892-899
184. lck: a role for SLP-76 in CD4-induced desensitization of the TCR/CD3 signaling complex. J Immunol 163:3143-3152
185. Sarin A, Wu ML, Henkart PA (1996) Different interleukin-1β converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli. J Exp Med 184:2445-2450
186. Sato T, Irie S, Kitada S, Reed JC (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268:411-415
187. Savill J, Dransfied I, Hogg N, Haslett C (1990) Vitronectin receptor-mediated phagocytosis of cells undergoing apoptosis. Nature 343:170-173
188. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187:1205-1213
189. Schönrich G, Kalinke U, Momburg F, Malissen M, Schmitt-Verhulst AM, Malissen B, Hämmerling GJ, Arnold B (1991) Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65:293-304
190. Schraven B, Peter ME (1995) APO-1(CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett 368:491-494
191. Schulze-Osthoff K, Walczak H, Dröge W, Krammer PH (1994) Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15-20
192. Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME (1998) Apoptosis signaling by death receptors. Eur J Biochem 254:439-459
193. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821
194. Shi Y, Sahai BM, Green DR (1989) Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 339:625-626
195. Shi Y, Szalay MG, Paskar L, Boyer M, Singh B, Green D (1990) Activation-induced cell death in T cell hybridomas is due to apoptosis. Morphologic aspects and DNA fragmentation. J Immunol 144:3326-3333
196. Shi Y, Bissonnette RP, Parfrey N, Szalay M, Kubo RT, Green DR (1991) In vivo administration of monoclonal antibodies to the CD3T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J Immunol 146:3340-3346
197. Sidman CL, Marshall JD, von Boehmer H (1992) Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22:499-504
198. Singer GG, Abbas AK (1994) The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-371
199. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJT (1989) Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337:181-144
200. + T cell mediated cytotoxicity. J Immunol 152:1127-1133
201. Stanger BZ, Leder P, Lee TH, Kim E, Seed B (1995) RIP: a novel protein containing a death domain that interacts with Fas/Apo-1 (CD95) in yeast and causes cell death. Cell 81:513-523
202. Suda T, Takahashi T, Golstein P, Nagata S (1993) Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75:1169-1178
203. Suda T, Okazaki T, Naizo Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S (1995) Expression of the Fas ligand in cells of T cell lineage. J Immunol 154:3806-3813
204. Suda T, Tanaka M, Miwa K, Nagata S (1996) Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 157: 3918-3924
205. Sytwu HK, Liblau RS, McDevitt HO (1996) The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17-30
206. + thymocytes are susceptible to DNA fragmentation induced by phorbol ester, calcium ionophore and anti-CD3 antibody. Eur J Immunol 20:779-784
207. Takahashi S, Maecker HT, Levy R (1989) DNA fragmentation and cell death mediated by T cell antigen receptor/CD3 complex on a leukemia T cell line. Eur J Immunol 19:1911-1919
208. Tanaka M, Suda T, Takahashi T, Nagata S (1995) Expression of the functional soluble form of human fas ligand in activated lymphocytes. EMBO J 14:1129-1135
209. Tanaka M, Itai T, Adachi M, Nagata S (1998) Downregulation of Fas ligand by shedding. Nature Medicine 4:31-36
210. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853
211. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462
212. Tian Q, Taupin JL, Elledge S, Robertson M, Anderson P (1995) Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 182:865-874
213. + T cells in the absence of TCR co-stimulation. Int Immunol 8:65-74
214. Trauth BC, Klas C, Peters AM, Matzku S, Möller P, Falk W, Debatin KM, Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301-305
215. Tschopp J, Irmler M, Thome M (1998) Inhibition of Fas death signals by FLIPs. Curr Opin Immunol 10:552-558
216. Tucek-Szabo CL, Andrjelic S, Lacy E, Elkon KB, Nikolic-Zugic J (1996) Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. J Immunol 156:192-200
217. vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells. J Exp Med 184:1161-1166
218. Ucker DS, Ashwell JD, Nickas G (1989) Activation-driven T cell death: requirements for de novo transcription and translation and association with genome fragmentation. J Immunol 143:3461-3469
219. Vander Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91:627-637
220. Varadhachary AS, Perdow SN, Hu C, Ramanarayanan M, Salgame P (1997) Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci USA 94:5778-5783
221. Verhoven B, Schlegel RA, Williamson P (1995) Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 182:1597-601
222. Vito P, Lacana E, D'Adamio L (1996) Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 271:521-525
223. Vukmanovic S, Zamoyska R (1991) Anti-CD3-induced cell death in T cell hybridomas: mitochondrial failure and DNA fragmentation are distinct events. Eur J Immunol 21:419-424
224. Walczak H, Degli-Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KAM, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J 16:5386-5397
225. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367
226. Wang ZQ, Dudhane A, Orlikowsky T, Clarke K, Li X, Darzynkiewicz Z, Hoffmann MK (1994) CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur J Immunol 24:1549-1152
227. + T cells. Eur J Immunol 26:2263-2270
228. Wange RL, Samelson LE (1996) Complex complexes: signaling at the TCR. Immunity 5:197-205
229. Wardenburg JB, Fu C, Jackman JK, Flotow H, Wilkinson SE, Williams DH, Johnson R, Kong G, Chan AC, Findell PR (1996) Phosphorylation of SLP-76 by the ZAP-70 protein tyrosine kinase is required for T-cell receptor function. J Biol Chem 271:19641-19644
230. Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, Okumura K, Miyatake S, Saito T (1997) Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death. Eur J Immunol 27:1858-1864
231. Webb S, Sprent J (1987) Downregulation of T cell responses by antibodies to the T cell receptor. J Exp Med 165:584-589
232. Webb S, Morris C, Sprent J (1990) Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell 63:1249-1256
233. Weih F, Ryseck RP, Chen L, Bravo R (1996) Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc Natl Acad Sci U S A 93:5533-5538
234. Wesselborg S, Prüfer U, Wild M, Schraven B, Meuer SC, Kabelitz D (1993a) Triggering via the alternative CD2 pathway induces apoptosis in activated human T lymphocytes. Eur J Immunol 23:2707-2710
235. Wesselborg S, Janssen O, Kabelitz D (1993b) Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 150:4338-4345
236. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang C-P, Nicholi JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995) Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
237. Williams GT, Smith CA, Spooncer E, Dexter TM, Taylor DR (1990) Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature 343:76-79
238. Wong B, Choi Y (1997) Pathways leading to cell death in T cells. Curr Opin Immunol 9:358-364
239. Woronicz JD, Calnan B, Ngo V, Winoto A (1994) Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277-280
240. Wu J, Motto DG, Koretzky GA, Weiss A (1996) Vav and SLP-76 interact and functionally cooperate in IL-2 gene activation. Immunity 4:593-602
241. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is assocated with endogenous endonuclease activation. Nature 184:555-556
242. Wyllie AH, Morris RG, Smith AL, Dunlop D (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 142:67-77
243. Yablonski D, Kuhne MR, Kadlecek T, Weiss A (1998) Uncoupling of nonreceptor tyrosine kinases from PLCγ1 in a SLP-76-deficient T cell. Science 281:413-416
244. Yang Y, Minucci S, Ozato K, Heyman RA, Ashwell JD (1995) Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem 270:18672-18677
245. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275:1129-1132
246. Yonehara S, Ishii A, Yonehara M (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor for tumor necrosis factor. J Exp Med 169: 1747-1756
247. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M, Kroemer G (1996) Mitochondrial control of nuclear apoptosis. J Exp Med 183:1533-1544
248. Zhang X, Brunner T, Carter L, Dutton RW, Rogers P, Bradley L, Sato T, Reed JC, Green D, Swain S (1997) Unequal death in T helper cell (Th)1 and Th2 effectors: Th1, but not Th2, effectors undergo rapid Fas/FasL-mediated apotosis. J Exp Med 185:1837-1847
249. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ (1995) Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351
250. Zhou P, Goldstein S, Devadas K, Tewari D, Notkins AL (1997) Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression. Nature Med 3:659-664